 CINCINNATI, April 19, 2021 GLOBE NEWSWIRE -- Meridian Bioscience, Inc. NASDAQ: VIVO, a provider of diagnostic testing solutions and life science raw materials, will report second quarter fiscal 2021 financial results Friday, May 7, 2021. 